APO Research
Talk to an analyst

APO RESEARCH · REPORT

Contrast Agents for Magnetic Resonance Imaging (MRI)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025198 pages

Choose your research edition.

Industry ResearchContrast Agents for Magnetic Resonance Imaging (MRI) Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Contrast Agents for Magnetic Resonance Imaging (MRI) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Contrast Agents for Magnetic Resonance Imaging (MRI) Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Contrast Agents for Magnetic Resonance Imaging (MRI) Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Contrast Agents for Magnetic Resonance Imaging (MRI) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Contrast Agents for Magnetic Resonance Imaging (MRI) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Contrast Agents for Magnetic Resonance Imaging (MRI) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Contrast Agents for Magnetic Resonance Imaging (MRI) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Contrast Agents for Magnetic Resonance Imaging (MRI) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Contrast Agents for Magnetic Resonance Imaging (MRI) include Daiichi Sankyo (Japan), Bayer HealthCare (Germany), Unijules Life Sciences (India), Taejoon Pharm (South Korea), Spago Nanomedicine (Sweden), Magnus Health (India), Lantheus (US), Jodas (India) and J.B. Chemicals and Pharmaceuticals (India), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Contrast Agents for Magnetic Resonance Imaging (MRI) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Contrast Agents for Magnetic Resonance Imaging (MRI) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Contrast Agents for Magnetic Resonance Imaging (MRI) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Contrast Agents for Magnetic Resonance Imaging (MRI) market size, projected growth trends, production technologies, key applications, and end-use industries.

Contrast Agents for Magnetic Resonance Imaging (MRI) Segment by Company

Daiichi Sankyo (Japan)

Bayer HealthCare (Germany)

Unijules Life Sciences (India)

Taejoon Pharm (South Korea)

Spago Nanomedicine (Sweden)

Magnus Health (India)

Lantheus (US)

Jodas (India)

J.B. Chemicals and Pharmaceuticals (India)

Guerbet (France)

GE Healthcare (US)

Bracco Imaging (Italy)

Contrast Agents for Magnetic Resonance Imaging (MRI) Segment by Type

Microbubble Contrast Media

Gadolinium-based Contrast Media

Iodinated Contrast Media

Barium-based Contrast Media

Contrast Agents for Magnetic Resonance Imaging (MRI) Segment by Application

Radiology

Interventional Radiology

Interventional Cardiology

Contrast Agents for Magnetic Resonance Imaging (MRI) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contrast Agents for Magnetic Resonance Imaging (MRI) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Contrast Agents for Magnetic Resonance Imaging (MRI) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contrast Agents for Magnetic Resonance Imaging (MRI).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Contrast Agents for Magnetic Resonance Imaging (MRI) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Contrast Agents for Magnetic Resonance Imaging (MRI) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Contrast Agents for Magnetic Resonance Imaging (MRI) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Contrast Agents for Magnetic Resonance Imaging (MRI) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Trends Table 2. Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Drivers Table 3. Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Opportunities and Challenges Table 4. Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Restraints Table 5. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Manufacturers Table 9. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturers, Product Type & Application Table 13. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Contrast Agents for Magnetic Resonance Imaging (MRI) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Microbubble Contrast Media Table 17. Major Manufacturers of Gadolinium-based Contrast Media Table 18. Major Manufacturers of Iodinated Contrast Media Table 19. Major Manufacturers of Barium-based Contrast Media Table 20. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2021-2026) & (k units) Table 22. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2027-2032) & (k units) Table 23. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2021-2026) Table 24. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2027-2032) Table 25. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2021-2026) & (k units) Table 27. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2027-2032) & (k units) Table 28. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Type (2021-2026) Table 29. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Radiology Table 31. Major Manufacturers of Interventional Radiology Table 32. Major Manufacturers of Interventional Cardiology Table 33. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2021-2026) & (k units) Table 35. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2027-2032) & (k units) Table 36. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2021-2026) Table 37. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2027-2032) Table 38. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2021-2026) & (k units) Table 40. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2027-2032) & (k units) Table 41. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Application (2021-2026) Table 42. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Application (2027-2032) Table 43. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region (2021-2026) & (k units) Table 45. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Region (2021-2026) Table 46. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021-2026) & (k units) Table 50. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2027-2032) & (k units) Table 51. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021-2026) & (k units) Table 53. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2027-2032) & (k units) Table 60. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Region (2021-2026) Table 64. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Region (2027-2032) Table 65. Daiichi Sankyo (Japan) Company Information Table 66. Daiichi Sankyo (Japan) Business Overview Table 67. Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 69. Daiichi Sankyo (Japan) Recent Development Table 70. Bayer HealthCare (Germany) Company Information Table 71. Bayer HealthCare (Germany) Business Overview Table 72. Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 74. Bayer HealthCare (Germany) Recent Development Table 75. Unijules Life Sciences (India) Company Information Table 76. Unijules Life Sciences (India) Business Overview Table 77. Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 79. Unijules Life Sciences (India) Recent Development Table 80. Taejoon Pharm (South Korea) Company Information Table 81. Taejoon Pharm (South Korea) Business Overview Table 82. Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 84. Taejoon Pharm (South Korea) Recent Development Table 85. Spago Nanomedicine (Sweden) Company Information Table 86. Spago Nanomedicine (Sweden) Business Overview Table 87. Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 89. Spago Nanomedicine (Sweden) Recent Development Table 90. Magnus Health (India) Company Information Table 91. Magnus Health (India) Business Overview Table 92. Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 94. Magnus Health (India) Recent Development Table 95. Lantheus (US) Company Information Table 96. Lantheus (US) Business Overview Table 97. Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 99. Lantheus (US) Recent Development Table 100. Jodas (India) Company Information Table 101. Jodas (India) Business Overview Table 102. Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 104. Jodas (India) Recent Development Table 105. J.B. Chemicals and Pharmaceuticals (India) Company Information Table 106. J.B. Chemicals and Pharmaceuticals (India) Business Overview Table 107. J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 109. J.B. Chemicals and Pharmaceuticals (India) Recent Development Table 110. Guerbet (France) Company Information Table 111. Guerbet (France) Business Overview Table 112. Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 114. Guerbet (France) Recent Development Table 115. GE Healthcare (US) Company Information Table 116. GE Healthcare (US) Business Overview Table 117. GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 119. GE Healthcare (US) Recent Development Table 120. Bracco Imaging (Italy) Company Information Table 121. Bracco Imaging (Italy) Business Overview Table 122. Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 124. Bracco Imaging (Italy) Recent Development Table 125. Key Raw Materials Table 126. Raw Materials Key Suppliers Table 127. Contrast Agents for Magnetic Resonance Imaging (MRI) Distributors List Table 128. Contrast Agents for Magnetic Resonance Imaging (MRI) Customers List Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Contrast Agents for Magnetic Resonance Imaging (MRI) Product Image Figure 2. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size (2021-2032) & (US$ Million) Figure 4. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (2021-2032) & (k units) Figure 5. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Contrast Agents for Magnetic Resonance Imaging (MRI) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Microbubble Contrast Media Image Figure 9. Gadolinium-based Contrast Media Image Figure 10. Iodinated Contrast Media Image Figure 11. Barium-based Contrast Media Image Figure 12. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2021-2032) Figure 15. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Type (2021-2032) Figure 18. Radiology Image Figure 19. Interventional Radiology Image Figure 20. Interventional Cardiology Image Figure 21. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2021-2032) Figure 24. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Application (2021-2032) Figure 27. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Country (2021-2032) Figure 29. U.S. Contrast Agents for Magnetic Resonance Imaging (MRI) Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Contrast Agents for Magnetic Resonance Imaging (MRI) Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Contrast Agents for Magnetic Resonance Imaging (MRI) Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Country (2021-2032) Figure 34. Germany Contrast Agents for Magnetic Resonance Imaging (MRI) Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Contrast Agents for Magnetic Resonance Imaging (MRI) Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Contrast Agents for Magnetic Resonance Imaging (MRI) Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Contrast Agents for Magnetic Resonance Imaging (MRI) Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Contrast Agents for Magnetic Resonance Imaging (MRI) Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Country (2021-2032) Figure 41. China Contrast Agents for Magnetic Resonance Imaging (MRI) Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Contrast Agents for Magnetic Resonance Imaging (MRI) Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Contrast Agents for Magnetic Resonance Imaging (MRI) Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Contrast Agents for Magnetic Resonance Imaging (MRI) Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Country (2021-2032) Figure 49. Brazil Contrast Agents for Magnetic Resonance Imaging (MRI) Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Contrast Agents for Magnetic Resonance Imaging (MRI) Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Contrast Agents for Magnetic Resonance Imaging (MRI) Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Contrast Agents for Magnetic Resonance Imaging (MRI) Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Contrast Agents for Magnetic Resonance Imaging (MRI) Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Contrast Agents for Magnetic Resonance Imaging (MRI) Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Figure 60. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Figure 62. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Contrast Agents for Magnetic Resonance Imaging (MRI) Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Contrast Agents for Magnetic Resonance Imaging (MRI) Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Microbubble Contrast Media
  • Gadolinium-based Contrast Media
  • Iodinated Contrast Media
  • Barium-based Contrast Media
Applications
  • Radiology
  • Interventional Radiology
  • Interventional Cardiology
Companies covered
  • Daiichi Sankyo (Japan)
  • Bayer HealthCare (Germany)
  • Unijules Life Sciences (India)
  • Taejoon Pharm (South Korea)
  • Spago Nanomedicine (Sweden)
  • Magnus Health (India)
  • Lantheus (US)
  • Jodas (India)
  • J.B. Chemicals and Pharmaceuticals (India)
  • Guerbet (France)
  • GE Healthcare (US)
  • Bracco Imaging (Italy)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Dynamics
  1. 2.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Trends
  2. 2.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Drivers
  3. 2.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Opportunities and Challenges
  4. 2.4 Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Restraints
3 Contrast Agents for Magnetic Resonance Imaging (MRI) Market by Manufacturers
  1. 3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturers, Product Type & Application
  7. 3.7 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Contrast Agents for Magnetic Resonance Imaging (MRI) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Contrast Agents for Magnetic Resonance Imaging (MRI) Tier 1, Tier 2, and Tier 3
4 Contrast Agents for Magnetic Resonance Imaging (MRI) Market by Type
  1. 4.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Type Introduction
  2. 4.1.1 Microbubble Contrast Media
  3. 4.1.2 Gadolinium-based Contrast Media
  4. 4.1.3 Iodinated Contrast Media
  5. 4.1.4 Barium-based Contrast Media
  6. 4.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type
  7. 4.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2021-2032)
  9. 4.2.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2021-2032)
  10. 4.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type
  11. 4.3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2021-2032)
  13. 4.3.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Type (2021-2032)
5 Contrast Agents for Magnetic Resonance Imaging (MRI) Market by Application
  1. 5.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Application Introduction
  2. 5.1.1 Radiology
  3. 5.1.2 Interventional Radiology
  4. 5.1.3 Interventional Cardiology
  5. 5.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application
  6. 5.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2021-2032)
  8. 5.2.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2021-2032)
  9. 5.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application
  10. 5.3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2021-2032)
  12. 5.3.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Application (2021-2032)
6 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region
  1. 6.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region (2021-2032)
  3. 6.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region (2021-2026)
  4. 6.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region
  1. 7.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region
  2. 7.1.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region (2021-2026)
  4. 7.1.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region (2027-2032)
  5. 7.1.4 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032)
  8. 7.2.2 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032)
  11. 7.3.2 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Daiichi Sankyo (Japan)
  2. 8.1.1 Daiichi Sankyo (Japan) Company Information
  3. 8.1.2 Daiichi Sankyo (Japan) Business Overview
  4. 8.1.3 Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  6. 8.1.5 Daiichi Sankyo (Japan) Recent Developments
  7. 8.2 Bayer HealthCare (Germany)
  8. 8.2.1 Bayer HealthCare (Germany) Company Information
  9. 8.2.2 Bayer HealthCare (Germany) Business Overview
  10. 8.2.3 Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  12. 8.2.5 Bayer HealthCare (Germany) Recent Developments
  13. 8.3 Unijules Life Sciences (India)
  14. 8.3.1 Unijules Life Sciences (India) Company Information
  15. 8.3.2 Unijules Life Sciences (India) Business Overview
  16. 8.3.3 Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  18. 8.3.5 Unijules Life Sciences (India) Recent Developments
  19. 8.4 Taejoon Pharm (South Korea)
  20. 8.4.1 Taejoon Pharm (South Korea) Company Information
  21. 8.4.2 Taejoon Pharm (South Korea) Business Overview
  22. 8.4.3 Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  24. 8.4.5 Taejoon Pharm (South Korea) Recent Developments
  25. 8.5 Spago Nanomedicine (Sweden)
  26. 8.5.1 Spago Nanomedicine (Sweden) Company Information
  27. 8.5.2 Spago Nanomedicine (Sweden) Business Overview
  28. 8.5.3 Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  30. 8.5.5 Spago Nanomedicine (Sweden) Recent Developments
  31. 8.6 Magnus Health (India)
  32. 8.6.1 Magnus Health (India) Company Information
  33. 8.6.2 Magnus Health (India) Business Overview
  34. 8.6.3 Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  36. 8.6.5 Magnus Health (India) Recent Developments
  37. 8.7 Lantheus (US)
  38. 8.7.1 Lantheus (US) Company Information
  39. 8.7.2 Lantheus (US) Business Overview
  40. 8.7.3 Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  42. 8.7.5 Lantheus (US) Recent Developments
  43. 8.8 Jodas (India)
  44. 8.8.1 Jodas (India) Company Information
  45. 8.8.2 Jodas (India) Business Overview
  46. 8.8.3 Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  48. 8.8.5 Jodas (India) Recent Developments
  49. 8.9 J.B. Chemicals and Pharmaceuticals (India)
  50. 8.9.1 J.B. Chemicals and Pharmaceuticals (India) Company Information
  51. 8.9.2 J.B. Chemicals and Pharmaceuticals (India) Business Overview
  52. 8.9.3 J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  54. 8.9.5 J.B. Chemicals and Pharmaceuticals (India) Recent Developments
  55. 8.10 Guerbet (France)
  56. 8.10.1 Guerbet (France) Company Information
  57. 8.10.2 Guerbet (France) Business Overview
  58. 8.10.3 Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  60. 8.10.5 Guerbet (France) Recent Developments
  61. 8.11 GE Healthcare (US)
  62. 8.11.1 GE Healthcare (US) Company Information
  63. 8.11.2 GE Healthcare (US) Business Overview
  64. 8.11.3 GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  66. 8.11.5 GE Healthcare (US) Recent Developments
  67. 8.12 Bracco Imaging (Italy)
  68. 8.12.1 Bracco Imaging (Italy) Company Information
  69. 8.12.2 Bracco Imaging (Italy) Business Overview
  70. 8.12.3 Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  72. 8.12.5 Bracco Imaging (Italy) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Value Chain Analysis
  2. 9.1.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Contrast Agents for Magnetic Resonance Imaging (MRI) Production Mode & Process
  6. 9.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Distributors
  9. 9.2.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst